Method comparison: where do we draw the line?

Articles in the same Issue

1. Editorial
2. Method comparison: where do we draw the line?
3. Review
4. Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods
5. Minireview
6. Molecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications
7. Opinion Paper
8. Preanalytical quality improvement: from dream to reality
9. Point
10. Towards more complete specifications for acceptable analytical performance – a plea for error grid analysis
11. Counterpoint
12. Closing the brain-to-brain loop in laboratory testing
13. General Clinical Chemistry and Laboratory Medicine
14. Harmonization of growth hormone measurements with different immunoassays by data adjustment
15. Comparison of the results from two different External Quality Assessment Schemes supports the utility of robust quality specifications
16. High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory
17. Performance of the Roche Total Mycophenolic Acid^® assay on the Cobas Integra 400^®, Cobas 6000^® and comparison to LC-MS/MS in liver transplant patients
18. Diagnostic efficiency of truncated area under the curve from 0 to 2 h (AUC_0–2) of mycophenolic acid in kidney transplant recipients receiving mycophenolate mofetil and concomitant tacrolimus
19. Good performance of an immunoassay based method for nevirapine measurements in human breast milk
20. Measurement of plasma amino acids by Ultraperformance^® Liquid Chromatography
21. Interchangeability of blood gas, electrolyte and metabolite results measured with point-of-care, blood gas and core laboratory analyzers
22. Granularity Index of the SYSMEX XE-5000 hematology analyzer as a replacement for manual microscopy of toxic granulation neutrophils in patients with inflammatory diseases
23. Direct chromogenic substrate immuno-capture activity assay for testing of factor VII-activating protease
24. The antinuclear antibody assay: developing criteria for reflexive anti-dsDNA antibody testing in a laboratory setting
25. A simple liquid chromatography-tandem mass spectrometry method for measuring metanephrine and normetanephrine in urine
26. Monoclonal gammopathy missed by capillary zone electrophoresis
27. Adaptation of the Diazyme Direct Enzymatic HbA_1c Assay for a microplate reader at room temperature
28. Validation and Outcome Studies
29. Laboratory assessment of iron status in pregnancy
30. Cardiovascular Diseases
31. Blood cells characteristics as determinants of acute myocardial infarction
32. No evidence for an association between the rs2824292 variant at chromosome 21q21 and ventricular fibrillation during acute myocardial infarction in a German population
33. Letters to the Editor
34. Letter to the Editor Reply: Statistical methods for assessment of added usefulness of new biomarkers
35. Reply to Vavrova et al. Clin Chem Lab Med 2011;49:89–92